Stockscreener 앱 받기
3.54
3.54%
-0.13
Yd Bio Ltd 주식(YDES)의 최신 뉴스
ETFs Investing in YD Bio Limited Stocks - TradingView
Top movers in Tuesday's pre-market session - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day - RTTNews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
YD Bio Launches Physician-Led Nutraceuticals in Taiwan to Build Consumer Health Ecosystem - TipRanks
YD Bio launches nutrition products via physician partnership model By Investing.com - Investing.com Australia
YD Bio launches nutrition products via physician partnership model - Investing.com
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute - Yahoo Finance
Two New Nutrition Formulas Bring YD Bio Into Taiwan Physician Network - Stock Titan
Top YD Bio (YDES) Competitors 2026 - MarketBeat
YD Bio Ord Shs (YDES) Stock News Today - TradingKey
Lantheus Holdings (LNTH) Holds Near $101 as Buyers Defend Key SupportForce Index - vinanet.vn
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research - Yahoo Finance
Keratoconus Study Ranks Molecules for Future Corneal Therapy Research - Stock Titan
YD Bio Launches Cross-Border Cancer Testing Pilot in Canada - Clinical Lab Products
YD Bio Limited (YDES) Climbs 5.55% to $2.32 as Buyers Eye Key ResistanceMFI Oversold - dars.gov.et
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada - The Manila Times
YD Bio launches pilot for cancer testing in British Columbia By Investing.com - Investing.com Canada
Five Cancer Types Targeted in YD Bio's Cross-Border Pilot - Stock Titan
Y.D. More group (TATT) reports 5.42% beneficial stake in TAT Technologies - Stock Titan
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Cash Flow - TradingKey
YDES|YD Bio Ord Shs|Price:2.350|Chg%:+0.110 - TradingKey
YD Bio Ord Shs (YDES) Balance Sheet - TradingKey
YDES|YD Bio Ord Shs|Price:2.300|Chg%:-0.020 - TradingKey
YD Bio Ord Shs (YDES) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
YD Bio Ord Shs (YDES) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
YD Bio Ord Shs (YDES) Institutional Confidence - TradingKey
YD Bio Ord Shs (YDES) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
YD Bio Ord Shs (YDES) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
YDES|YD Bio Ord Shs|Price:2.240|Chg%:+0.200 - TradingKey
YD Bio Ord Shs (YDES) Income Statement - TradingKey
YD Bio Limited (YDES) Surges 7.7% as Shares Test Key Resistance at $2.35Statistical Arbitrage - dars.gov.et
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
30 Prospective Partners Explore Cancer Tests and Eye Care at Taiwan Expo - Stock Titan
Diabetic Macular Edema Pipeline 2026: MOA, ROA, FDA-Approved - openPR.com
Gapping stocks in Wednesday's session - ChartMill
YDESW Warrants Surge 6.67%: Key Levels and Technical Outlook for YD Bio Limited WarrantsCollar Trade - dars.gov.et
Enterprise value to revenue forward of YD Bio Limited – NASDAQ:YDES - TradingView
Enterprise value to EBIT forward of YD Bio Limited – NASDAQ:YDES - TradingView
PLPC Q1 2026 Earnings: EPS Surprises to the Upside, but Stock DeclinesAnnual Report - dars.gov.et
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Which stocks have an unusual volume on Tuesday? - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
YD Bio (YDESW) Stock Analysis Report | Financials & Insights - Benzinga España
YD Bio affiliate obtains lab licenses in Rhode Island, Pennsylvania - Investing.com
YD Bio affiliate obtains lab licenses in Rhode Island, Pennsylvania By Investing.com - Investing.com Canada
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - Yahoo Finance
YD Bio expands cancer-testing lab access to 46 states - Stock Titan
RSU grant and exercise update for YD Bio (YDES) director Lu - Stock Titan
RSU grant and exercise for YD Bio (YDES) director Chang Kochi - Stock Titan
YD Bio Ltd (NASDAQ: YDES) Share Price, YDES Stock News, YDES Share Price & Updates - Kalkine
YD Bio Limited (YDES) Faces Resistance as Shares Decline Nearly 3%New Listing Stocks - dars.gov.et
MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility - Yahoo Finance
Morning Market Movers: CUPR, BNC, ABSI, WEN See Big Swings - RTTNews
BRZHR Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
0.86%
0.31%
자본화:
|
볼륨(24시간):